Corrigendum to "Patterns of some extracellular matrix gene expression are similar in cells from cleft lip-palate patients and in human palatal fibroblasts exposed to diazepam in culture" [Toxicology 257 (2009) 10-16] (DOI:10.1016/j.tox.2008.12.002);Patterns of some extracellular matrix gene expression are similar in cells from cleft lip-palate patients and in human palatal fibroblasts exposed to diazepam in culture

Toxicology

Volumn 257, Issue 1-2, 2009, Pages 10-16

  Marinucci, Lorella ^a   Balloni, Stefania ^a   Bodo, Maria ^a   Carinci, Francesco ^b   Pezzetti, Furio ^c   Stabellini, Giordano ^d   Carmela, Conte ^a   Lumare, Eleonora ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

Cleft palate fibroblasts; Diazepam; ECM proteins; FGF2; GABRB3; Integrins; Metalloproteases; TGF 3

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; COLLAGEN; COLLAGENASE 3; DIAZEPAM; FIBROBLAST GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 2; FIBROMODULIN; GAMMA AMINOBUTYRIC ACID RECEPTOR B3; GROWTH FACTOR; INTEGRIN; METALLOPROTEINASE; SCLEROPROTEIN; TENASCIN; TRANSFORMING GROWTH FACTOR BETA3; UNCLASSIFIED DRUG; VITRONECTIN;

ARTICLE; CELL CULTURE; CHILD; CLEFT LIP; CLEFT PALATE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FIBROBLAST; GABAERGIC SYSTEM; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; ORGANOGENESIS; PALATE; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; UPREGULATION;

EID: 58649117963     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2009.02.001     Document Type: Erratum

References (58)

1. Ameye L., Aria D., Jepsen K., Oldberg A., Xu T., and Young M.F. Abnormal collagen fibris in tendons of biglycan/fibromodulin-deficient mice lead to gait impairment, ectopic ossification, and osteoarthritis. FASEB J. 16 (2002) 673-680
2. Ameye L.G., Deberg M., Oliveira M., Labasse A., Aeschlimann J.M., and Henrotin Y. The chemical biomarkers C2C, Coll2-1, and Coll2-1NO2 provide complementary information on type II collagen catabolism in healthy and osteoarthritic mice. Arthritis Rheum. 56 (2007) 3336-3346
3. Atfi A., Dumont E., Colland F., Bonnier D., L'Helgoualc'h A., Prunier C., Ferrand N., Clement B., Wewer U.M., and Theret N. The disintegrin and metalloproteinase ADAM12 contributes to TGF-β signalling through interaction with the type II receptor. J. Cell Biol. 176 (2007) 201-208
4. 3 regulates extracellular matrix production by human fibroblasts from subjects with non-syndromic cleft lip and palate. J. Periodontol. 74 (2003) 1447-1453
5. Baroni T., Bellucci C., Lilli C., Pezzetti F., Carinci F., Becchetti E., Carinci P., Stabellini G., Calvitti M., Lumare E., and Bodo M. Retinoic acid, GABA-ergic, and TGF-β signalling systems are involved in human cleft palate fibroblast phenotype. Mol. Med. 12 (2006) 237-245
6. Bergman U., Rosa F.W., Baum C., Wiholm B.E., and Faich G.A. Effects of exposure to benzodiazepine during fetal life. Lancet 340 (1992) 694-696
7. Bodo M., Baroni T., Carinci F., Becchetti E., Bellucci C., Conte C., Pezzetti F., Evangelisti R., Tognon M., and Carinci P. A regulatory role of fibroblast growth factor in the expression of decorin, biglycan, betaglycan and syndecan in osteoblasts from patients with Crouzon's syndrome. Eur. J. Cell Biol. 78 (1999) 323-330
8. Bodo M., Baroni T., Carinci F., Becchetti E., Bellucci C., Pezzetti F., Conte C., Evangelisti R., and Carinci P. TGFβ isoforms and decorin gene expression are modified in fibroblasts obtained from non-syndromic cleft lip and palate subjects. J. Dent. Res. 78 (1999) 1783-1790
9. Bosi G., Evangelisti R., Valeno V., Carinci F., Pezzetti F., Calastrini C., Bodo M., and Carinci P. Diphenylhydantoin affects glycosaminoglycans and collagen production by human fibroblasts from cleft palate patients. J. Dent. Res. 77 (1998) 1613-1621
10. Carinci F., Scapoli L., Palmieri A., Zollino I., and Pezzetti F. Human genetic factors in nonsyndromic cleft lip and palate: an update. Int. J. Pediatr. Otorhinolaryngol. 71 (2007) 1509-1519
11. Czeizel A. Lack of evidence of evidence of teratogenicity of benzodiazepine drugs in Hungary. Reprod. Toxicol. 1 3 (1987) 183-188
12. Corsi A., Xu T., Chen X.D., Boyde A., Liang J., Mankani M., Sommer B., Iozzo R.V., Eichstetter I., Robey P.G., Bianco P., and Young M.F. Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues. J. Bone Miner. Res. 17 (2002) 1180-1189
13. Cossart R., Bernard C., and Ben-Ari Y. Multiple facets of GABAergic neurons and synapses: multiple fates of GABA signalling in epilepsies. Trends Neurosci. 28 (2005) 108-115
14. Danfelter M., Onnerfjord P., and Heinegard D. Fragmentation of proteins in cartilage treated with interleukin-1: specific cleavage of type IX collagen by matrix metalloproteinase 13 releases the NC4 domain. J. Biol. Chem. 282 (2007) 36933-36941
15. De Ruijter J.E., ter Brugge P.J., Dieudonne S.C., van Vliet S.J., Torensma R., and Jansen J.A. Analysis of integrin expression in U2OS cells cultured on various calcium phosphate ceramic substrates. Tissue Eng. 7 (2001) 279-289
16. Dolovich L.R., Addis A., Vaillancourt J.M., Power J.D., Koren G., and Einarson T.R. Benzodiazepine use in pregnancy and major malformations or oral meta-analysis of cohort and case-control studies. BMJ 317 (1998) 839-843
17. Farrant M., and Nusser Z. Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors. Nat. Rev. Neurosci. 6 (2005) 215-229
18. Fukushima Y., Tamura M., Nakagawa H., and Itoh K. Induction of glioma cell migration by vitronectin in human serum and cerebrospinal fluid. J. Neurosurg. 10 (2007) 578-585
19. Gritli-Linde A. Molecular control of secondary palate development. Dev. Biol. 301 (2007) 309-326
20. Hartz S.C., Heinonen O.P., Shapiro S., Siskind V., and Slone D. Antenatal exposure to meprobamate and chlordiazepoxide in relation to malformations, mental development, and childhood mortality. N. Engl. J. Med. 292 (1975) 726-728
21. Hollier B.G., Kricker J.A., Van Lonkhuyzen D.R., Leavesley D.I., and Upton Z. Substrate-bound IGF-I:IGFBP:Vitronectin-stimulated breast cell migration is enhanced by co-activation of the PI3-K/AKT pathway by alpha v-integrins and the IGF-1R. Endocrinology 149 (2008) 1075-1090
22. Homanics G.E., Ferguson C., Quinlan J.J., Daggett J., Snyder K., Lagenaur C., Mi Z.P., Wang X.H., Grayson D.R., and Fireston L.L. Gene knockout of the alpha6 subunit of the gamma-aminobutyric acid type A receptor: lack of effect on responses to ethanol, pentobarbital, and general anesthetics. Mol. Pharmacol. 51 (1997) 588-596
23. Jurand A., and Martin L.V. Cleft palate and open eyelids inducing activity of lorazepam and the effect of flumazenil, the benzodiazepine antagonist. Pharmacol. Toxicol. 74 (1994) 228-235
24. Katz R.A. Effect of diazepam on the embryonic development of the palate in the rat. J. Craniofac. Genet. Dev. Biol. 8 (1988) 155.166
25. Laegreid L., Olegard R., Conradi N., Hagberg G., Wahlstrom J., and Abrahamsson L. Congenital malformations and maternal consumption of benzodiazepines: a case-control study. Dev. Med. Child. Neurol. 32 (1990) 432-441
26. Laegreid L. Clinical observations in children after prenatal benzodiazepine exposure. Dev. Pharmacol. Ther. 15 (1990) 186-188
27. A receptor microscopic affinity. Neuropharmacology 35 (1996) 1383-1392
28. Lee D.C., Luetteke N.C., Qiu T.H., Chen X., and Berkowitz E.A. Transforming growth factor alpha: its expression, regulation, and role in transformation. In: Tsang R.C., Lemons J.A., and Balistreri W.E. (Eds). Growth Factors in Perinatal Development (1993), Raven Press, New York 21-38
29. 3 with nonsyndromic clefting in humans. Am. J. Hum. Genet. 63 (1998) 557-568
30. Marinucci L., Lilli C., Guerra M., Belcastro S., Becchetti E., Stabellini G., Calvi E.M., and Locci P. Biocompatibility of collagen membranes cross-linked with glutaraldehyde or diphenylphosphoryl azide: an in vitro study. J. Biomed. Mater. Res. 67 (2003) 504-509
31. McNally A.K., Jones J.A., Macewan S.R., Colton E., and Anderson J.M. Vitronectin is a critical protein adhesion substrate for IL-4-induced foreign body giant cell formation. J. Biomed. Mater. Res. (2007) (Epub ahead of print)
32. A receptors. Brain Res. Rev. 29 (1999) 196-217
33. Mino Y., Mizusawa H., and Shiota K. Effects of anticonvulsant drugs on fetal mouse palates cultured in vitro. Reprod. Toxicol. 8 (1994) 225-230
34. Nakamura I., Duongle T., Rodan S.B., and Rodan G.A. Involvement of alpha(v)beta3 integrins in osteoclast function. J. Bone Miner. Metab. 25 (2007) 337-344
35. Nie X., Luukko K., and Kettunen P. FGF signalling in craniofacial development and developmental disorders. Oral Dis. 12 (2006) 102-111
36. Osoegawa K., Vessere G.M., Utami K.H., Mansilla M.A., Johnson M.K., Riley B.M., L'heureux J., Pfundt R., Staaf J., Van der Vliet W.A., Lidral A.C., Schoenmakers E.F., Borg A., Schutte B.C., Lammer E.J., Murray J.C., and De Jong P.J. Identification of novel candidate genes associated with cleft lip and palate using array comparative genomic hybridisation. J. Med. Genet. 45 (2008) 81-86
37. Pauws E., and Stanier P. FGF signalling and SUMO modification: new players in the aetiology of cleft lip and/or palate. Trends Genet. 23 (2007) 631-640
38. Pawlikowski M., Kunert-Radek J., Radek A., and Stepien H. Inhibition of cell proliferation of human gliomas by benzodiazepines in vitro. Acta Neurol. Scand. 77 (1988) 231-233
39. Pezzetti F., Scapoli L., Martinelli M., Carinci F., Bodo M., Carinci P., and Tognon M. A locus in 2p13-p14 (OFC2), in addition to that mapped in 6p23, is involved in nonsyndromic familial orofacial cleftmalformation. Genomics 50 (1998) 299-305
40. Proetzel G., Pawlowski S.A., Wiles M.V., Yin M., Boivin G.P., Howles P.N., Ding J., Ferguson M.W., and Doetschman T. Transforming growth factor beta 3 is required for secondary palate fusion. Nat. Genet. 11 (1995) 409-414
41. Ratheesh A., Ingle A., and Gude R.P. Pentoxifylline modulates cell surface integrin expression and integrin mediated adhesion of B16F10 cells to extracellular matrix components. Cancer Biol. Ther. 6 (2007) 1743-1752
42. Riley B.M., and Murray J.C. Sequence evaluation of FGF and FGFR gene conserved non-coding elements in non syndromic cleft lip and palate cases. Am. J. Med. Genet. A 143 (2007) 3228-3234
43. Saxen I. Associations between oral clefts and drugs taken during pregnancy. Int. J. Epidemiol. 4 (1975) 37-44
44. Scapoli L., Pezzetti F., Carinci F., Martinelli M., Carinci P., and Tognon M. Genetic heterogeneity and evidence of linkare to 6p23 in nonsyndromic cleft lip with or without cleft palate. Genomics 43 (1997) 216-220
45. Scapoli L., Pezzetti F., Carinci F., Martinelli M., Carinci P., and Tognon M. Lack of linkage disequilibrium between transforming growth factor alpha Taq I polymorphism and cleft lip with or without cleft palate in families from northeastern Italy. Am. J. Med. Gen. 75 (1998) 203-206
46. Scapoli L., Martinelli M., Pezzetti F., Carinci F., Bodo M., Tognon M., and Carinci P. Linkage disequilibrium between GABRB3 gene and non-syndromic familial cleft ip with or without cleft palate. Hum. Genet. 110 (2002) 15-20
47. Schar C.R., Blouse G.E., Minor K.H., and Peterson C.B. A deletion mutant of vitronectin lacking the somatomedin B domain exhibits residual pai-1-binding activity. J. Biol. Chem. 283 (2008) 10297-10309
48. Siebers M.C., ter Brugge P.J., Walboomers X.F., and Jansen J.A. Integrins as linker proteins between osteoblasts and bone replacing materials. A critical review. Biomaterials 26 (2005) 137-146
49. St Clair S.M., and Schirmer R.G. First-trimester exposure to alprazolam. Obstet. Gynecol. 80 5 (1992) 843-846
50. Ter Brugge P.J., Torensma R., De Ruijter J.E., Figdor C.G., and Jansen J.A. Modulation of integrin expression on rat bone marrow cells by substrates with different surface characteristics. Tissue Eng. 8 (2002) 615-626
51. Tomczuk M., Takahashi Y., Huang J., Murase S., Mistretta M., Klaffky E., Sutherland A., Bolling L., Coonrod S., Marcinkiewicz C., Sheppard D., Stepp M.A., and White J.M. Role of multiple beta1 integrins in cell adhesion to the disintegrin domains of ADAMs 2 and 3. Exp. Cell Res. 290 (2003) 68-81
52. Wadhwa S., Embree M.C., Kilts T., Young M.F., and Ameye L.G. Accelerated osteoarthritis in the temporomandibular joint of biglycan/fibromodulin double-deficient mice. Osteoarthr. Cartilage 13 (2005) 817-827
53. Wee E.L., and Zimmerman E.F. Involvement of GABA in palate morphogenesis and its relation to diazepam teratogenesis in two mouse strains. Teratology 28 (1983) 15-22
54. Wolfsberg T.G., Primakoff P., Myles D.G., and White J.M. ADAM, a novel family of membrane proteins containing a disintegrin and metalloprotease domain: multipotential functions in cell-cell and cell-matrix interactions. J. Cell Biol. 131 (1995) 275-278
55. Young M.F., Bi Y., Ameye L., and Chen X.D. Biglycan knockout mice: new models for musculoskeletal diseases. Glycoconj. J. 19 (2002) 257-262
56. Zimmerman E.F. Neuropharmacologic teratogenesis and neurotransmitter regulation of palate development. Am. J. Ment. Defic. 88 (1984) 548-558
57. Zimmerman E.F., Venkatasubramanian K., and Wee E.L. Role of neurotransmitters and teratogens on palate development. Prog. Clin. Biol. Res. 163C (1985) 405-408
58. Zimmerman E.F. Role of neurotransmitters in palate development and teratologic implications. Prog. Clin. Biol. Res. 171 (1985) 283-294